Artivion(AORT) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results
PR NewswireApr 21 16:10 ET
Investors in Artivion (NYSE:AORT) Have Seen Returns of 15% Over the Past Year
Yahoo FinanceApr 14 08:58 ET
Artivion (NYSE:AORT) Might Have The Makings Of A Multi-Bagger
Simply Wall StApr 8 07:55 ET
Do Options Traders Know Something About Artivion (AORT) Stock We Don't?
Zacks Mar 24 11:35 ET
Congressmember Tina Smith's New Portfolio Holdings
Quiver QuantitativeMar 20 16:00 ET
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Dow JonesMar 17 16:53 ET

Comments

Jerry Kronenberg

Feb 25 05:30

Columns Artivion Falls 8% on Q4 Sales and Adjusted EPS Misses

$Artivion (AORT.US)$ fell more than 8% after hours Monday after the medical-device company missed analyst estimates for its Q4 revenues and adjusted earnings per share.
AORT sank 8.1% to $25.60 shortly before 4:30 p.m. ET after the company reported zero adjusted earnings per share on $97.3 million of revenues. That trailed the $0.04 in adjusted EPS on $100.8 million of revenues that analysts had expected.
Management also guided 2025 sales to $4...

1

Moomoo AI

Jan 19, 2024 05:10

Artivion's management optimizes capital structure for a new phase of profitable growth. Strong conviction in business outlook, recent financial performance and clinical data readouts expected to deliver significant shareholder value.

Press Release: Artivion Obtains $350 Million in Senior Secured Credit Facilities

Moomoo AI

Nov 7, 2023 02:48

Artivion's reinvestment has not significantly improved sales, resulting in a 52% decline in stock over the past five years. The market perspective shows skepticism, implying Artivion may not have substantial growth potential.